Report Detail
Global Infantile Spasm Treatment Market Growth (Status and Outlook) 2019-2024
- RnM3190521 |
- 26 March, 2019 |
- Global |
- 115 Pages |
- LPI(LP Information) |
- Other
An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.
According to this study, over the next five years the Infantile Spasm Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Infantile Spasm Treatment business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Infantile Spasm Treatment market by product type, application, key companies and key regions.
This study considers the Infantile Spasm Treatment value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Oral
Parenteral
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospital
Clinic
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Mallinckrodt
H. Lundbeck
Insys Therapeutics
Orphelia Pharma
Valerion Therapeutics
Catalyst Pharmaceuticals
Anavex Life Sciences
Retrophin
GW Pharmaceuticals
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Infantile Spasm Treatment market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Infantile Spasm Treatment market by identifying its various subsegments.
Focuses on the key global Infantile Spasm Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Infantile Spasm Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Infantile Spasm Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Infantile Spasm Treatment Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Infantile Spasm Treatment Market Size 2014-2024
- 2.1.2 Infantile Spasm Treatment Market Size CAGR by Region
- 2.2 Infantile Spasm Treatment Segment by Type
- 2.2.1 Oral
- 2.2.2 Parenteral
- 2.3 Infantile Spasm Treatment Market Size by Type
- 2.3.1 Global Infantile Spasm Treatment Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Infantile Spasm Treatment Market Size Growth Rate by Type (2014-2019)
- 2.4 Infantile Spasm Treatment Segment by Application
- 2.4.1 Hospital
- 2.4.2 Clinic
- 2.4.3 Other
- 2.5 Infantile Spasm Treatment Market Size by Application
- 2.5.1 Global Infantile Spasm Treatment Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Infantile Spasm Treatment Market Size Growth Rate by Application (2014-2019)
3 Global Infantile Spasm Treatment by Players
- 3.1 Global Infantile Spasm Treatment Market Size Market Share by Players
- 3.1.1 Global Infantile Spasm Treatment Market Size by Players (2017-2019)
- 3.1.2 Global Infantile Spasm Treatment Market Size Market Share by Players (2017-2019)
- 3.2 Global Infantile Spasm Treatment Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Infantile Spasm Treatment by Regions
- 4.1 Infantile Spasm Treatment Market Size by Regions
- 4.2 Americas Infantile Spasm Treatment Market Size Growth
- 4.3 APAC Infantile Spasm Treatment Market Size Growth
- 4.4 Europe Infantile Spasm Treatment Market Size Growth
- 4.5 Middle East & Africa Infantile Spasm Treatment Market Size Growth
5 Americas
- 5.1 Americas Infantile Spasm Treatment Market Size by Countries
- 5.2 Americas Infantile Spasm Treatment Market Size by Type
- 5.3 Americas Infantile Spasm Treatment Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Infantile Spasm Treatment Market Size by Countries
- 6.2 APAC Infantile Spasm Treatment Market Size by Type
- 6.3 APAC Infantile Spasm Treatment Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Infantile Spasm Treatment by Countries
- 7.2 Europe Infantile Spasm Treatment Market Size by Type
- 7.3 Europe Infantile Spasm Treatment Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Infantile Spasm Treatment by Countries
- 8.2 Middle East & Africa Infantile Spasm Treatment Market Size by Type
- 8.3 Middle East & Africa Infantile Spasm Treatment Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Infantile Spasm Treatment Market Forecast
- 10.1 Global Infantile Spasm Treatment Market Size Forecast (2019-2024)
- 10.2 Global Infantile Spasm Treatment Forecast by Regions
- 10.2.1 Global Infantile Spasm Treatment Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Infantile Spasm Treatment Forecast by Type
- 10.8 Global Infantile Spasm Treatment Forecast by Application
11 Key Players Analysis
- 11.1 Mallinckrodt
- 11.1.1 Company Details
- 11.1.2 Infantile Spasm Treatment Product Offered
- 11.1.3 Mallinckrodt Infantile Spasm Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 Mallinckrodt News
- 11.2 H. Lundbeck
- 11.2.1 Company Details
- 11.2.2 Infantile Spasm Treatment Product Offered
- 11.2.3 H. Lundbeck Infantile Spasm Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 H. Lundbeck News
- 11.3 Insys Therapeutics
- 11.3.1 Company Details
- 11.3.2 Infantile Spasm Treatment Product Offered
- 11.3.3 Insys Therapeutics Infantile Spasm Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Insys Therapeutics News
- 11.4 Orphelia Pharma
- 11.4.1 Company Details
- 11.4.2 Infantile Spasm Treatment Product Offered
- 11.4.3 Orphelia Pharma Infantile Spasm Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 Orphelia Pharma News
- 11.5 Valerion Therapeutics
- 11.5.1 Company Details
- 11.5.2 Infantile Spasm Treatment Product Offered
- 11.5.3 Valerion Therapeutics Infantile Spasm Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 Valerion Therapeutics News
- 11.6 Catalyst Pharmaceuticals
- 11.6.1 Company Details
- 11.6.2 Infantile Spasm Treatment Product Offered
- 11.6.3 Catalyst Pharmaceuticals Infantile Spasm Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 Catalyst Pharmaceuticals News
- 11.7 Anavex Life Sciences
- 11.7.1 Company Details
- 11.7.2 Infantile Spasm Treatment Product Offered
- 11.7.3 Anavex Life Sciences Infantile Spasm Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 Anavex Life Sciences News
- 11.8 Retrophin
- 11.8.1 Company Details
- 11.8.2 Infantile Spasm Treatment Product Offered
- 11.8.3 Retrophin Infantile Spasm Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Retrophin News
- 11.9 GW Pharmaceuticals
- 11.9.1 Company Details
- 11.9.2 Infantile Spasm Treatment Product Offered
- 11.9.3 GW Pharmaceuticals Infantile Spasm Treatment Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 GW Pharmaceuticals News
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Infantile Spasm Treatment . Industry analysis & Market Report on Infantile Spasm Treatment is a syndicated market report, published as Global Infantile Spasm Treatment Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Infantile Spasm Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
